These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18672385)

  • 1. Comparison of add-on valproate and primidone in carbamazepine-unresponsive patients with partial epilepsy.
    Sun MZ; Deckers CL; Liu YX; Wang W
    Seizure; 2009 Mar; 18(2):90-3. PubMed ID: 18672385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Open randomized comparative trial of sodium valproate and carbamazepine in adult onset epilepsy].
    Czapiński P; Terczyński A
    Neurol Neurochir Pol; 1996; 30(3):419-26. PubMed ID: 8965976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New statistical method for analyzing time to first seizure: example using data comparing carbamazepine and valproate monotherapy.
    Cowling BJ; Shaw JE; Hutton JL; Marson AG
    Epilepsia; 2007 Jun; 48(6):1173-8. PubMed ID: 17553118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The LAM-SAFE Study: lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults.
    Steinhoff BJ; Ueberall MA; Siemes H; Kurlemann G; Schmitz B; Bergmann L;
    Seizure; 2005 Dec; 14(8):597-605. PubMed ID: 16278088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind substitution of vigabatrin and valproate in carbamazepine-resistant partial epilepsy. 012 Study group.
    Brodie MJ; Mumford JP
    Epilepsy Res; 1999 Apr; 34(2-3):199-205. PubMed ID: 10210035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative efficacy of carbamazepine, valproic acid and topiramate in symptomatic and cryptogenic occipital lobe epilepsy in children].
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Suppl 1):39-44. PubMed ID: 20559266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy.
    Lee BI; No SK; Yi SD; Lee HW; Kim OJ; Kim SH; Kim MK; Kim SE; Kim YS; Kim JM; Lee SJ; Shin DJ; Park SP; Kim YI; Heo K; Cho YW; Cho YJ; Kim YN
    Seizure; 2018 Feb; 55():17-24. PubMed ID: 29324401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
    Zeng K; Wang X; Xi Z; Yan Y
    Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical side effects of phenobarbital, primidone, phenytoin, carbamazepine, and valproate during monotherapy in children.
    Herranz JL; Armijo JA; Arteaga R
    Epilepsia; 1988; 29(6):794-804. PubMed ID: 3142761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
    Fountain NB; Conry JA; Rodríguez-Leyva I; Gutierrez-Moctezuma J; Salas E; Coupez R; Stockis A; Lu ZS
    Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of levetiracetam drug levels to assist with seizure control and monitoring of drug interactions with other anti-epileptic medications (AEMs).
    Stepanova D; Beran RG
    Seizure; 2014 May; 23(5):371-6. PubMed ID: 24630809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies.
    Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
    Epilepsia; 2006 Jul; 47(7):1121-7. PubMed ID: 16886974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiepileptic monotherapy and combination therapy of simple focal seizures].
    Fröscher W; Stoll KD
    Fortschr Neurol Psychiatr; 1985 Dec; 53(12):447-53. PubMed ID: 3935555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of sodium valproate in partial epilepsy. Crossed study of valproate and carbamazepine].
    Loiseau P; Cohadon S; Jogeix M; Legroux M; Dartigues JF
    Rev Neurol (Paris); 1984; 140(6-7):434-7. PubMed ID: 6431586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the retention rates between carbamazepine and valproate as an initial monotherapy in Chinese patients with partial seizures: A ten-year follow-up, observational study.
    Hu Y; Huang Y; Quan F; Hu Y; Lu Y; Wang XF
    Seizure; 2011 Apr; 20(3):208-13. PubMed ID: 21159526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative efficacy of carbamazepine, valproic acid and topiramate in symptomatic and cryptogenic occipital lobe epilepsy in children].
    Boldyreva SR; Ermakov AIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Pt 1):39-44. PubMed ID: 21322824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome evaluation of gabapentin as add-on therapy for partial seizures. "NEON" Study Investigators Group. Neurontin Evaluation of Outcomes in Neurological Practice.
    Bruni J
    Can J Neurol Sci; 1998 May; 25(2):134-40. PubMed ID: 9604135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamotrigine-valproic acid combination therapy for medically refractory epilepsy.
    Moeller JJ; Rahey SR; Sadler RM
    Epilepsia; 2009 Mar; 50(3):475-9. PubMed ID: 19054403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
    Jozwiak S; Terczynski A
    Seizure; 2000 Oct; 9(7):486-92. PubMed ID: 11034873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological outcomes in newly diagnosed epilepsy.
    Mohanraj R; Brodie MJ
    Epilepsy Behav; 2005 May; 6(3):382-7. PubMed ID: 15820347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.